Evrópusambandið - portúgalska - EMA (European Medicines Agency)

sanofi winthrop industrie - sarilumab - artrite, reumatóide - imunossupressores - o kevzara em combinação com metotrexato (mtx) é indicado para o tratamento de artrite reumatóide (ar) moderada a severamente ativa em pacientes adultos que responderam inadequadamente ou que são intolerantes a uma ou mais drogas anti-reumáticas modificadoras de doença (dmards). kevzara pode ser administrado em monoterapia em caso de intolerância ao mtx ou quando o tratamento com mtx é inadequado.

Evrópusambandið - portúgalska - EMA (European Medicines Agency)

sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - agentes para dermatite, excluindo corticosteróides - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.

Evrópusambandið - portúgalska - EMA (European Medicines Agency)

sanofi pasteur - chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated) - a dengue - vacinas - dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4. 2, 4. 4 e 4. o uso de dengvaxia deve estar em conformidade com as recomendações oficiais.

Brasilía - portúgalska - ANVISA (Agência Nacional de Vigilância Sanitária)

sanofi-aventis farmacÊutica ltda - acido acetilsalicilico - analgesicos nao narcoticos

Brasilía - portúgalska - ANVISA (Agência Nacional de Vigilância Sanitária)

sanofi-aventis farmacÊutica ltda - Ácido acetilsalicÍlico - antiagregante plaquetario

Brasilía - portúgalska - ANVISA (Agência Nacional de Vigilância Sanitária)

sanofi medley farmacÊutica ltda. - acebrofilina - broncodilatadores

Brasilía - portúgalska - ANVISA (Agência Nacional de Vigilância Sanitária)

sanofi medley farmacÊutica ltda. - acetato de clostebol, sulfato de neomicina - ceratoliticos e ceratoplasticos

Brasilía - portúgalska - ANVISA (Agência Nacional de Vigilância Sanitária)

sanofi medley farmacÊutica ltda. - acetato de clostebol, sulfato de neomicina - ceratoliticos e ceratoplasticos

Brasilía - portúgalska - ANVISA (Agência Nacional de Vigilância Sanitária)

sanofi-aventis farmacÊutica ltda - cloridrato de fexofenadina - anti-histaminicos sistemicos

Brasilía - portúgalska - ANVISA (Agência Nacional de Vigilância Sanitária)

sanofi-aventis farmacÊutica ltda - cloridrato de fexofenadina, cloridrato de pseudoefedrina - descongestionantes nasais sistemicos